Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for BioRestorative Therapies (BRTX) over the last 7 years, with Q3 2025 value amounting to $9.1 million.

  • BioRestorative Therapies' Shares Outstanding (Diluted Average) rose 1224.74% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year increase of 1224.74%. This contributed to the annual value of $7.8 million for FY2024, which is 8405.15% up from last year.
  • As of Q3 2025, BioRestorative Therapies' Shares Outstanding (Diluted Average) stood at $9.1 million, which was up 1224.74% from $8.7 million recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Shares Outstanding (Diluted Average) ranged from a high of $12.3 million in Q3 2023 and a low of $729930.0 during Q1 2021
  • Over the past 5 years, BioRestorative Therapies' median Shares Outstanding (Diluted Average) value was $5.4 million (recorded in 2023), while the average stood at $5.8 million.
  • In the last 5 years, BioRestorative Therapies' Shares Outstanding (Diluted Average) tumbled by 9995.01% in 2021 and then surged by 108825.25% in 2022.
  • Over the past 5 years, BioRestorative Therapies' Shares Outstanding (Diluted Average) (Quarter) stood at $838689.0 in 2021, then soared by 331.37% to $3.6 million in 2022, then grew by 16.6% to $4.2 million in 2023, then surged by 84.05% to $7.8 million in 2024, then rose by 17.42% to $9.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $9.1 million in Q3 2025, compared to $8.7 million in Q2 2025 and $8.4 million in Q1 2025.